Search | IOVS | ARVO Journals

Showing 1 – 20 of 42

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

The Characterization of the Ang-2 Arm of a Novel Anti-VEGF-A and Ang-2 Bispecific Protein (RO-101) in Comparison to Faricimab-svoa

Megana Paidela; Li Xu; Parth Patel; John Mitchell Kunzeman; Jessi Prentice; Robert Lowenthal; Mark Barakat; Arshad M. Khanani; Peter K Kaiser; Jeffrey L. Olson; Jeffrey S Heier; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):739.

ARVO Annual Meeting Abstract June 2023

Binding Characteristics of the VEGF Arm of a Novel Bispecific Protein RO-101 in Comparison to Faricimab-svoa

Parth Patel; Li Xu; Megana Paidela; John Mitchell Kunzeman; Jessi Prentice; Mark Barakat; Robert Lowenthal; Arshad M. Khanani; Peter M Kaiser; Jeffrey S Heier; Jeffrey L. Olson; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):738.

ARVO Annual Meeting Abstract June 2022

Assessing Inhibition of HUVEC Migration by a Novel VEGF-A and Angiopoietin-2 Bispecific Protein (RO-634)

John Kunzeman; Jeffrey L Olson; Anthony Jones; Josh Morgenstern; Anne Strong; Steven Droho; Shaun Bevers; Niklaus Mueller; Michael Huvard; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; Nikhil Gupta; Alina Sinha; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1325 – F0159.

ARVO Annual Meeting Abstract June 2022

The Half Maximal Effective Concentration (EC50) of a Novel VEGF-A and Ang-2 Bispecific Protein (RO-634) for Back of the Eye Disease

Alina Sinha; Jeffrey L Olson; Anthony Jones; Josh Morgenstern; Anne Strong; Steven Droho; Shaun Bevers; Niklaus Mueller; Michael Huvard; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; John M Kunzeman; Evan Sembell; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1316 – F0150.

ARVO Annual Meeting Abstract June 2022

ASCORBIC ACID ATTENUATES HYDROGEN PEROXIDE INDUCED OXIDATIVE STRESS AND OSTEOBLASTS DEMONSTRATE ANTIOXIDANT RECYCLING POTENTIAL

Richard Tran; Joshua Morgenstern; Steven Droho; Jeffrey L Olson

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):375 – F0206.

ARVO Annual Meeting Abstract June 2022

Characterizing a Novel Bispecific Platform (Surrobody) for use in Back of the Eye Disease

Ramanath Bhandari; Li Xu; Evan Sembell; Jeffrey L Olson; Peter M Kaiser; Arshad M. Khanani; Jeffrey S Heier; Alina Sinha; John M Kunzeman; Nikhil Gupta; Ramesh Bhatt

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):302 – F0105.

ARVO Annual Meeting Abstract June 2022

Determining the Ocular Biocompatibility of a Novel VEGF-A and Ang-2 Bispecific Protein (RO-634) Through Histological Analysis

Evan Sembell; Jeffrey L Olson; Anthony Jones; Josh Morgenstern; Anne Strong; Steven Droho; Niklaus Mueller; Michael Huvard; Shaun Bevers; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; Nikhil Gupta; John M Kunzeman; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):305 – F0108.

ARVO Annual Meeting Abstract June 2022

Preclinical Animal Model for Functional Biocompatibility of a Novel VEGF and Ang-2 Bispecific Protein (RO-634) Using ERG Analysis

Nikhil Gupta; Jeffrey L Olson; Anthony Jones; Josh Morgenstern; Anne Strong; Steven Droho; Shaun Bevers; Niklaus Mueller; Michael Huvard; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; Alina Sinha; Evan Sembell; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):286 – F0089.

ARVO Annual Meeting Abstract June 2022

RO-634 half-life as compared to published data on Aflibercept, Faricimab, Ranibizumab, and Bevacizumab.

Zafar Gill; Jeffrey L Olson; Josh Morgenstern; Anthony Jones; Anne Strong; Steven Droho; Shaun Bevers; Niklaus Mueller; Nihaal Mehta; Michael Huvard; Peter K Kaiser; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):308 – F0111.

ARVO Annual Meeting Abstract June 2020

RPE cellular morphology and intracellular autofluorescence after suppression of vitreous complement levels

Anthony Jones; Joshua Logan Morgenstern; Jeffrey L Olson

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):318.

ARVO Annual Meeting Abstract June 2020

Polyacrylonitrile implant prevents retinal photoreceptor degeneration in a mouse model of AMD

Joshua L Morgenstern; Anthony Jones; Anne D Strong; Ellen Rhodes; Eric R Williams; Jeffrey L Olson

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):322.

ARVO Annual Meeting Abstract July 2019

A Novel Surrobody Reduces Neovascularization in a Rat Model of CNV

Anthony Abraham Jones; Joshua L. Morgenstern; Anne D. Strong; Jeffrey Olson

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):132.

ARVO Annual Meeting Abstract September 2016

Concurrent Inner Limiting Membrane Peeling During Epiretinal Membrane Surgery: Effects on Outcomes and Recurrence

Logan Christensen; Jeffrey Olson

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1056.

ARVO Annual Meeting Abstract September 2016

Correlation of diabetic macular edema intraretinal cyst reflectivity on SD-OCT to anti-VEGF treatment response

Nathan R Haines; Riley Sanders; Richard Yi-Jen Hwang; Jeffrey Olson

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4168.

ARVO Annual Meeting Abstract June 2015

Enhanced High-density Line Spectral-domain Optical Coherence Tomography Imaging of Vitreoretinal Interface. Description of Selected Cases

Yu Cheol Kim; Mariana Harasawa; Guillermo Salcedo Villanueva; Frank S Siringo; Miguel Paciuc-Beja; Jeffrey Olson; Naresh Mandava; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1232.

ARVO Annual Meeting Abstract June 2015

Tobacco Use as a Risk Factor For Proliferative Vitreoretinopathy

Frank S Siringo; Jeffrey Olson; Scott Oliver; Marc Mathias; Naresh Mandava; Jesse M Smith

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1414.

ARVO Annual Meeting Abstract June 2015

Adsorption of VEGF to Hydroxyapatite

Richard Yi-Jen Hwang; Raul Velez; Sergio Groman-Lupa; Yu Cheol Kim; Jeffrey Olson

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):149.

ARVO Annual Meeting Abstract June 2015

Ocular Biocompatibility of Nitinol

Nicole Nghiem; David A Ammar; Mark Petrash; Jeffrey Olson

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1542.

ARVO Annual Meeting Abstract June 2015

Adsorption of Complement Factor D by polyacrylonitrile hollow fiber membrane

Anna Mackin; Jeffrey Olson

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5730.

ARVO Annual Meeting Abstract June 2015

Biotic Implant for Local Oxygenation

Jeffrey Olson

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2479.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

The Characterization of the Ang-2 Arm of a Novel Anti-VEGF-A and Ang-2 Bispecific Protein (RO-101) in Comparison to Faricimab-svoa

Binding Characteristics of the VEGF Arm of a Novel Bispecific Protein RO-101 in Comparison to Faricimab-svoa

Assessing Inhibition of HUVEC Migration by a Novel VEGF-A and Angiopoietin-2 Bispecific Protein (RO-634)

The Half Maximal Effective Concentration (EC50) of a Novel VEGF-A and Ang-2 Bispecific Protein (RO-634) for Back of the Eye Disease

ASCORBIC ACID ATTENUATES HYDROGEN PEROXIDE INDUCED OXIDATIVE STRESS AND OSTEOBLASTS DEMONSTRATE ANTIOXIDANT RECYCLING POTENTIAL

Characterizing a Novel Bispecific Platform (Surrobody) for use in Back of the Eye Disease

Determining the Ocular Biocompatibility of a Novel VEGF-A and Ang-2 Bispecific Protein (RO-634) Through Histological Analysis

Preclinical Animal Model for Functional Biocompatibility of a Novel VEGF and Ang-2 Bispecific Protein (RO-634) Using ERG Analysis

RO-634 half-life as compared to published data on Aflibercept, Faricimab, Ranibizumab, and Bevacizumab.

RPE cellular morphology and intracellular autofluorescence after suppression of vitreous complement levels

Polyacrylonitrile implant prevents retinal photoreceptor degeneration in a mouse model of AMD

A Novel Surrobody Reduces Neovascularization in a Rat Model of CNV

Concurrent Inner Limiting Membrane Peeling During Epiretinal Membrane Surgery: Effects on Outcomes and Recurrence

Correlation of diabetic macular edema intraretinal cyst reflectivity on SD-OCT to anti-VEGF treatment response

Enhanced High-density Line Spectral-domain Optical Coherence Tomography Imaging of Vitreoretinal Interface. Description of Selected Cases

Tobacco Use as a Risk Factor For Proliferative Vitreoretinopathy

Adsorption of VEGF to Hydroxyapatite

Ocular Biocompatibility of Nitinol

Adsorption of Complement Factor D by polyacrylonitrile hollow fiber membrane

Biotic Implant for Local Oxygenation

To View More...

You must be signed into an individual account to use this feature.